Clinical Trials on Rapidly Progressive Glomerulonephritis in United Kingdom
Total 892 results
-
Alentis Therapeutics AGRecruitingGlomerulonephritis Rapidly ProgressiveCzechia, Spain, Denmark, Italy, United Kingdom, Germany, France, Switzerland, Sweden
-
Imperial College Healthcare NHS TrustCompletedGlomerulonephritis, MembranousUnited Kingdom
-
Mayo ClinicMallinckrodtCompletedProteinuria | Progressive IgA NephropathyUnited States
-
University of GlasgowNHS Ayrshire and Arran; AKMCompletedMultiple Sclerosis, ProgressiveUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Cambridge; Medical Research Council Mitochondrial Biology UnitCompletedMitochondrial Diseases | Mitochondrial Myopathies | Progressive External Ophthalmoplegia | Progressive Ophthalmoplegia | Progressive; Ophthalmoplegia, External | Mitochondria DNA Deletion | MELASUnited Kingdom
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Alexion PharmaceuticalsCompletedC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit DiseaseUnited Kingdom, United States
-
University of LincolnNottingham University Hospitals NHS TrustCompletedDepression | Secondary-progressive Multiple SclerosisUnited Kingdom
-
Manchester University NHS Foundation TrustFresenius AGCompletedAutoimmune Membranous NephropathyUnited Kingdom
-
North Bristol NHS TrustUniversity of Nottingham; Medical Research Council; University of Bristol; Bristol... and other collaboratorsUnknownProgressive Multiple SclerosisUnited Kingdom
-
University of GlasgowNHS Ayrshire and Arran; AKMCompletedProgressive Multiple SclerosisUnited Kingdom
-
GlaxoSmithKlineCompletedGlomerulonephritis, MembranousUnited Kingdom
-
Glasgow Caledonian UniversityUnknown
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University College, LondonCompletedAlzheimer Disease | Frontotemporal Dementia | Primary Progressive AphasiaUnited Kingdom
-
Charite University, Berlin, GermanyBerlin Institute of HealthActive, not recruitingGlomerulonephritis AcuteUnited Kingdom, Germany
-
University College London HospitalsCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
BioCryst PharmaceuticalsTerminatedImmunoglobulin A Nephropathy | Membranous Nephropathy | Complement 3 GlomerulopathyFrance, Italy, Spain, United Kingdom
-
University of NottinghamNottingham University Hospitals NHS TrustCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Daval International LimitedUnknownSecondary Progressive Multiple SclerosisUnited Kingdom
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Australia, Brazil, Czechia, France, Italy, Korea, Republic of, Netherlands, Spain, Switzerland, United Kingdom
-
Celldex TherapeuticsTerminatedC3 Glomerulonephritis | Dense Deposit Disease | Membranoproliferative Glomerulonephritis Type IIUnited States
-
University of NottinghamRecruitingParkinson Disease | Progression, DiseaseUnited Kingdom
-
University College, LondonNational Multiple Sclerosis SocietyCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
St George's, University of LondonUnknownAirway Morbidity | High Flow Oxygen in Rapid Sequence InductionUnited Kingdom
-
Apellis Pharmaceuticals, Inc.Active, not recruitingRenal Transplant | C3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative... and other conditionsUnited States, Australia, Austria, United Kingdom, Brazil, Argentina, France, Italy, Netherlands, Spain, Switzerland
-
Imperial College LondonGlaxoSmithKline; University College, London; Medical Research Council; Queen Mary... and other collaboratorsCompletedRelapsing-remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
University of LeicesterTravere Therapeutics, Inc.Active, not recruitingImmune System Diseases | Autoimmune Diseases | Kidney Diseases | Glomerulonephritis | Immunoglobulin A Nephropathy | Glomerulonephritis, IGAUnited Kingdom
-
University College, LondonUniversity of Oxford; Newcastle University; University of Cambridge; University... and other collaboratorsRecruitingCorticobasal Degeneration | Multiple System Atrophy (MSA) | Progressive Supranuclear Palsy (PSP)United Kingdom
-
Mayo ClinicCompletedGlomerulonephritis, MembranoproliferativeUnited States
-
Apellis Pharmaceuticals, Inc.AvailableC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)WithdrawnMyelodysplastic Syndromes | Progressive DiseaseUnited States
-
Imperial College LondonCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Columbia UniversityAlexion PharmaceuticalsCompletedDense Deposit Disease | Membranoproliferative GlomerulonephritisUnited States
-
Alnylam PharmaceuticalsTerminatedIgA Nephropathy (IgAN) | Berger Disease | Glomerulonephritis, IgACanada, Malaysia, France, Sweden, United Kingdom, Philippines, Singapore, Spain, Taiwan
-
University of OxfordUCB BelgiumRecruitingParkinson Disease | Progressive Supranuclear PalsyUnited Kingdom
-
Fernando FervenzaCompleted
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Spain, France, Germany, United Kingdom, Netherlands, Brazil, Israel, Japan, Australia, Austria, Italy, Switzerland, Korea, Republic of, Czechia, Belgium, Argentina, Canada, Poland
-
Novartis PharmaceuticalsTerminatedGlomerulonephritis, MembranousCzechia, India, Taiwan, United Kingdom, Germany, Argentina, China, Netherlands, Spain
-
Imperial College LondonUnknownSepsis | Deterioration, ClinicalUnited Kingdom
-
Omeros CorporationRecruitingC3 Glomerulopathy | Idiopathic Immune Complex-Mediated GlomerulonephritisLithuania, New Zealand, Poland, Tunisia, Turkey, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingProgressive Supranuclear Palsy (PSP)Germany, United Kingdom, Canada, United States
-
Rigel PharmaceuticalsCompletedIGA NephropathyUnited States, United Kingdom, Hong Kong, Taiwan, Austria, Germany
-
University College, LondonLondon School of Hygiene and Tropical Medicine; The Leeds Teaching Hospitals... and other collaboratorsActive, not recruitingSecondary Progressive Multiple Sclerosis (SPMS)United Kingdom
-
Mayo ClinicGenentech, Inc.CompletedFibrillary GlomerulonephritisUnited States
-
AlexionTerminatedIC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Membranoproliferative GlomerulonephritisUnited States, Australia, Belgium, Italy, Netherlands
-
Cambridge University Hospitals NHS Foundation TrustWithdrawnLupus NephritisUnited Kingdom
-
University of OxfordNational Institute for Health Research, United KingdomRecruitingSurgery | Deterioration, ClinicalUnited Kingdom
-
King's College LondonAssistance Publique - Hôpitaux de Paris; Aventis Pharmaceuticals; University...TerminatedMultiple System Atrophy | Progressive Supranuclear PalsyUnited Kingdom
-
Anthera PharmaceuticalsCompletedIgA NephropathyCzechia, Germany, Hong Kong, Korea, Republic of, Malaysia, Philippines, Singapore, Taiwan, Thailand, United Kingdom